NEW YORK (Reuters Health) – Anemia increases the risk of bleeding and death after percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI), a new study shows.…
NEW YORK (Reuters Health) – The advantages of primary percutaneous coronary intervention (PCI) over fibrinolysis for patients with ST-segment elevation myocardial infarction (STEMI) are maintained for 8 years,…
NEW YORK (Reuters Health) – To reduce the risk of adverse ischemic outcomes and death, angioplasty should be done within 24 hours of presentation for non-ST-segment elevation acute…
NEW YORK (Reuters Health) – Drug-eluting stents in saphenous vein grafts have a lower risk of revascularization than bare-metal stents, according to a meta-analysis of data on nearly…
Program OverviewThe Best Practice Series in Heart Failure is a series of 3-4 minute videos featuring top physicians discussing the best ways to diagnose and treat Heart Failure…
NEW YORK (Reuters Health) – Just 38% of patients with suspected cardiac disease are found to have obstructive coronary disease on elective cardiac catheterization, new research shows. This…
NEW YORK (Reuters Health) – Three years after ST-segment elevation myocardial infarction (STEMI), sirolimus-eluting stents still provide better protection against major adverse cardiovascular events compared to bare metal…
NEW YORK (Reuters Health) – Using a distal filter to protect against emboli during coronary stent implantation increases long-term rates of stent thrombosis and target vessel revascularization, investigators…
NEW YORK (Reuters Health) – Percutaneous extraction of pacemaker or implantable cardioverter-defibrillator (ICD) leads is safe in patients with cardiac vegetations, investigators report. And as long as blood…
Richard J Shemin, MD, Chief of Cardiothoracic Surgery, UCLA David Geffen School of Medicine, discusses hybrid approaches to cardiology and cardiothoracic surgery, such as operation rooms where interventional…